Latest Hemacare Corp (HEMA) Headlines 2013 Re
Post# of 7
Posted On: 03/10/2014 2:55:54 AM
Latest Hemacare Corp (HEMA) Headlines
2013 Report on the International Apheresis Equipment Market - Trends and Forecasts to 2018
M2 - Wed Jan 22, 8:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/ft7f6d/apheresis) has announced the addition of the "2013 Report on the International Apheresis Equipment Market - Trends and Forecasts to 2018" report to their offering. This report covers the performance of various segments of the apheresis market in terms of revenues generated in such segments. The overall market is classified on the basis of the types of applications of apheresis, different procedural modalities of therapeutic apheresis, various technologies employed, and the types of equipment used in apheresis. The report provides in-depth analysis of the sub-segments of the market with their estimated forecast of market size from 2010 to 2018. The data analyses the estimated revenues and forecast of these major applications for the period 2012 - 2018. Similar analysis is performed for the procedure modalities of apheresis and types of technology used in therapeutic apheresis. This report also includes analysis of the global apheresis equipment market, which is further segmented on the basis of geographical distribution. The overall analysis of the competitiveness of the global apheresis equipment market is covered in the report. The above mentioned key analysis with recommendations would be of assistance in taking strategic decisions related to the market. This research is specifically prepared to analyze and estimate the performance of the major apheresis equipment segments in the global market. The study also presents a comprehensive assessment of the major strategies of the market stakeholders and their winning imperatives by segmenting the market as follows: Key Topics Covered: 1 Introduction 2 Executive Summary 3 Apheresis Equipment Market Overview 4 Global Apheresis Equipment Market, By Applications 5 Apheresis Equipment Market, By Types Of Procedures 6 Global Apheresis Machines Market, By Technology 7 Global Apheresis Equipment Market, By Geography 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Asahi Kasei Kuraray Medical Co., Ltd. - B. Braun Melsungen AG - Fenwal, Inc. - Haemonetics Corp. - Hemacare Corporation - Terumo BCT, Inc. - Therakos, Inc. For more information visit http://www.researchandmarkets.com/research/ft7f6d/apheresis
Global Apheresis Equipment Market Report 2013 - 2018
M2 - Mon Nov 18, 5:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/jlpwt8/apheresis) has announced the addition of the "Global Apheresis Equipment Market Report 2013 - 2018" report to their offering. The applications equipment market is classified on the basis of types of clinical areas in which the apheresis procedure is employed. The report covers the analysis of the estimated revenues and forecast of these major applications for the period 2012 - 2018. Similar analysis is performed for the procedure modalities of apheresis and types of technology used in therapeutic apheresis. This report also includes analysis of the global apheresis equipment market, which is further segmented on the basis of geographical distribution. The overall analysis of the competitiveness of the global apheresis equipment market is covered in the report. The above mentioned key analysis with recommendations would be of assistance in taking strategic decisions related to the market. Further, this report also covers the major firms that are active in the apheresis market. The company profiles included in the report will be of significant help in understanding the tactical overview of the market. The company profiling performed in the report covers the financial and strategic properties, SWOT analysis, and the recent developments of the major players of the global apheresis market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Apheresis Equipment Market Overview 3.1 Introduction 3.2 Therapeutic Apheresis 3.3 Donor Apheresis 3.4 Market Dynamics 3.5 Porter's Five Forces Analysis 3.6 Market Attractiveness Analysis 3.7 Market Share Analysis, 2011 4 Global Apheresis Equipment Market, By Applications 4.1 Introduction 4.2 Neurological Disorders 4.3 Hematology 4.4 Renal Disorders 4.5 Others 5 Apheresis Equipment Market, By Types Of Procedures 5.1 Introduction 5.2 Plasmapheresis 5.3 Photopheresis 5.4 Leukapheresis 5.5 Plateletpheresis 5.6 LDL Apheresis 5.7 Erythrocytapheresis 5.8 Others (Lymphapheresis, Lipidpheresis) 6 Global Apheresis Machines Market, By Technology 7 Global Apheresis Equipment Market, By Geography 7.1 Introduction 7.2 North America 7.3 Europe 7.4 Asia Pacific 7.5 Rest Of World 8 Competitive Landscape 8.1 Introduction 8.2 Major Strategies By Key Players 8.3 Recommendations 9 Company Profiles Companies Mentioned - Asahi Kasei Kuraray Medical Co., Ltd. - B. Braun Melsungen AG - Fenwal, Inc. - Haemonetics Corp. - Hemacare Corporation - Terumo BCT, Inc. - Therakos, Inc. For more information visit http://www.researchandmarkets.com/research/jlpwt8/apheresis
2013 Report on the Worldwide Apheresis Market - with Forecasts to 2017
M2 - Fri Nov 01, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7b5s5q/apheresis_market) has announced the addition of the "2013 Report on the Worldwide Apheresis Market - with Forecasts to 2017" report to their offering. Apheresis involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. Apheresis applications market studied in this report is segmented as plasmapheresis, plateletapheresis, erythrocytapheresis, leukapheresis, and other applications based on the various components collected in apheresis collection and therapeutic apheresis. The apheresis market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market. The global apheresis market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017 growing at a CAGR of 11.0% from 2012 to 2017. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Apheresis Market, By Procedure 5 Global Apheresis Market, By Product Type 6 Global Apheresis Market, By Technology 7 Global Apheresis Market, By Application 8 Geographic Analysis 8.1 Introduction 8.2 North America 8.3 Europe 8.4 Asia 8.5 Row (Rest Of The World) 9 Competitive Landscape 9.1 Introduction 9.2 Mergers & Acquisitions 9.3 Agreements, Partnerships, Collaborations & Joint Ventures 9.4 Products Launch 9.5 Expansions 9.6 Other Developments 9.7 Approvals 10 Company Profiles Companies Mentioned - Asahi Kasei Medical - B. Braun Melsungen - Cerus Corporation - Fenwal - Fresenius Medical Care Ag & Co - Haemonetics Corporation - Hemacare Corporation - Kaneka Corporation - Kawasumi Laboratories - Medica S.P.A - Nikkiso Co - Terumo Bct - Therakos For more information visit http://www.researchandmarkets.com/research/7b...sis_market
HemaCare Announces Sale of Coral Blood Services Assets and Reports Six Month Results
Business Wire - Thu Oct 10, 2:50PM CDT
HemaCare Corporation has completed the sale of its Coral Blood Services subsidiary to the New York Blood Center ("NYBC"). Financial terms of the transaction were not disclosed. Coral's 24 employees have been offered equivalent positions at NYBC.
BioLife Solutions Announces Strategic Partnership with HemaCare
PR Newswire - Tue Jun 25, 5:00AM CDT
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, (OTCPK:HEMA), a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic relationship wherein HemaCare will market BioLife's HypoThermosol® and CryoStor® biopreservation media products and HemaCare's blood derived cells to the research and clinical communities.
HemaCare Reports Improved Six Month and Year End Results
Business Wire - Mon Mar 18, 8:00AM CDT
HemaCare Corporation (HEMA) today reported its financial results for the six months and year ended December 31, 2012. For the six month period, revenue rose by 13% to $9.2 million, while the loss from continuing operations decreased by 83% to $214,000 when compared to the year-earlier period. For the year ended December 31, 2012, revenue rose by 10% to $17.9 million, while the loss from continuing operations decreased by 65% to $758,000 compared to the year-earlier period. Total Company income was $1,163,000 for the year ended December 31, 2012 compared with a total Company loss of $805,000 for the year ended December 31, 2011.
Apheresis Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
M2 - Thu Feb 28, 10:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/ztn2dt/apheresis) has announced the addition of the "Apheresis Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering. Apheresis Equipment Market (Plasmapheresis, Photopheresis, Apheresis in Neurological, Renal, Hematological Diseases, Centrifugation, Membrane Filtration, Apheresis Machines and Disposable Kits) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 This report on the global apheresis equipment market includes the different facets of therapeutic apheresis, donor apheresis, and the apheresis devices market. The report covers the performance of various segments of the apheresis market in terms of revenues generated in such segments. The overall market is classified on the basis of the types of applications of apheresis, different procedural modalities of therapeutic apheresis, various technologies employed, and the types of equipmen
Apheresis Market - Applications, Procedures, Devices & Disposables - Forecasts To 2017
M2 - Wed Jan 16, 9:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/sfgngk/apheresis_market) has announced the addition of the "Apheresis Market - Applications (Plasmapheresis, Plateletpheresis,RBC/Erythrocytapheresis,Leukapheresis,Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices & Disposables - Forecasts To 2017" report to their offering. Apheresis is a process in which blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of separated component. Apheresis involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. Apheresis applications market studied in this report is segmented as plasmapheresis, plateletapheresis, erythrocytapheresis, leukapheresis, and other applications based on the various components collected in apheresis collection
2013 Report on the International Apheresis Equipment Market - Trends and Forecasts to 2018
M2 - Wed Jan 22, 8:47AM CST
Research and Markets (http://www.researchandmarkets.com/research/ft7f6d/apheresis) has announced the addition of the "2013 Report on the International Apheresis Equipment Market - Trends and Forecasts to 2018" report to their offering. This report covers the performance of various segments of the apheresis market in terms of revenues generated in such segments. The overall market is classified on the basis of the types of applications of apheresis, different procedural modalities of therapeutic apheresis, various technologies employed, and the types of equipment used in apheresis. The report provides in-depth analysis of the sub-segments of the market with their estimated forecast of market size from 2010 to 2018. The data analyses the estimated revenues and forecast of these major applications for the period 2012 - 2018. Similar analysis is performed for the procedure modalities of apheresis and types of technology used in therapeutic apheresis. This report also includes analysis of the global apheresis equipment market, which is further segmented on the basis of geographical distribution. The overall analysis of the competitiveness of the global apheresis equipment market is covered in the report. The above mentioned key analysis with recommendations would be of assistance in taking strategic decisions related to the market. This research is specifically prepared to analyze and estimate the performance of the major apheresis equipment segments in the global market. The study also presents a comprehensive assessment of the major strategies of the market stakeholders and their winning imperatives by segmenting the market as follows: Key Topics Covered: 1 Introduction 2 Executive Summary 3 Apheresis Equipment Market Overview 4 Global Apheresis Equipment Market, By Applications 5 Apheresis Equipment Market, By Types Of Procedures 6 Global Apheresis Machines Market, By Technology 7 Global Apheresis Equipment Market, By Geography 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Asahi Kasei Kuraray Medical Co., Ltd. - B. Braun Melsungen AG - Fenwal, Inc. - Haemonetics Corp. - Hemacare Corporation - Terumo BCT, Inc. - Therakos, Inc. For more information visit http://www.researchandmarkets.com/research/ft7f6d/apheresis
Global Apheresis Equipment Market Report 2013 - 2018
M2 - Mon Nov 18, 5:24AM CST
Research and Markets (http://www.researchandmarkets.com/research/jlpwt8/apheresis) has announced the addition of the "Global Apheresis Equipment Market Report 2013 - 2018" report to their offering. The applications equipment market is classified on the basis of types of clinical areas in which the apheresis procedure is employed. The report covers the analysis of the estimated revenues and forecast of these major applications for the period 2012 - 2018. Similar analysis is performed for the procedure modalities of apheresis and types of technology used in therapeutic apheresis. This report also includes analysis of the global apheresis equipment market, which is further segmented on the basis of geographical distribution. The overall analysis of the competitiveness of the global apheresis equipment market is covered in the report. The above mentioned key analysis with recommendations would be of assistance in taking strategic decisions related to the market. Further, this report also covers the major firms that are active in the apheresis market. The company profiles included in the report will be of significant help in understanding the tactical overview of the market. The company profiling performed in the report covers the financial and strategic properties, SWOT analysis, and the recent developments of the major players of the global apheresis market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Apheresis Equipment Market Overview 3.1 Introduction 3.2 Therapeutic Apheresis 3.3 Donor Apheresis 3.4 Market Dynamics 3.5 Porter's Five Forces Analysis 3.6 Market Attractiveness Analysis 3.7 Market Share Analysis, 2011 4 Global Apheresis Equipment Market, By Applications 4.1 Introduction 4.2 Neurological Disorders 4.3 Hematology 4.4 Renal Disorders 4.5 Others 5 Apheresis Equipment Market, By Types Of Procedures 5.1 Introduction 5.2 Plasmapheresis 5.3 Photopheresis 5.4 Leukapheresis 5.5 Plateletpheresis 5.6 LDL Apheresis 5.7 Erythrocytapheresis 5.8 Others (Lymphapheresis, Lipidpheresis) 6 Global Apheresis Machines Market, By Technology 7 Global Apheresis Equipment Market, By Geography 7.1 Introduction 7.2 North America 7.3 Europe 7.4 Asia Pacific 7.5 Rest Of World 8 Competitive Landscape 8.1 Introduction 8.2 Major Strategies By Key Players 8.3 Recommendations 9 Company Profiles Companies Mentioned - Asahi Kasei Kuraray Medical Co., Ltd. - B. Braun Melsungen AG - Fenwal, Inc. - Haemonetics Corp. - Hemacare Corporation - Terumo BCT, Inc. - Therakos, Inc. For more information visit http://www.researchandmarkets.com/research/jlpwt8/apheresis
2013 Report on the Worldwide Apheresis Market - with Forecasts to 2017
M2 - Fri Nov 01, 5:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7b5s5q/apheresis_market) has announced the addition of the "2013 Report on the Worldwide Apheresis Market - with Forecasts to 2017" report to their offering. Apheresis involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. Apheresis applications market studied in this report is segmented as plasmapheresis, plateletapheresis, erythrocytapheresis, leukapheresis, and other applications based on the various components collected in apheresis collection and therapeutic apheresis. The apheresis market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market. The global apheresis market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017 growing at a CAGR of 11.0% from 2012 to 2017. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Global Apheresis Market, By Procedure 5 Global Apheresis Market, By Product Type 6 Global Apheresis Market, By Technology 7 Global Apheresis Market, By Application 8 Geographic Analysis 8.1 Introduction 8.2 North America 8.3 Europe 8.4 Asia 8.5 Row (Rest Of The World) 9 Competitive Landscape 9.1 Introduction 9.2 Mergers & Acquisitions 9.3 Agreements, Partnerships, Collaborations & Joint Ventures 9.4 Products Launch 9.5 Expansions 9.6 Other Developments 9.7 Approvals 10 Company Profiles Companies Mentioned - Asahi Kasei Medical - B. Braun Melsungen - Cerus Corporation - Fenwal - Fresenius Medical Care Ag & Co - Haemonetics Corporation - Hemacare Corporation - Kaneka Corporation - Kawasumi Laboratories - Medica S.P.A - Nikkiso Co - Terumo Bct - Therakos For more information visit http://www.researchandmarkets.com/research/7b...sis_market
HemaCare Announces Sale of Coral Blood Services Assets and Reports Six Month Results
Business Wire - Thu Oct 10, 2:50PM CDT
HemaCare Corporation has completed the sale of its Coral Blood Services subsidiary to the New York Blood Center ("NYBC"). Financial terms of the transaction were not disclosed. Coral's 24 employees have been offered equivalent positions at NYBC.
BioLife Solutions Announces Strategic Partnership with HemaCare
PR Newswire - Tue Jun 25, 5:00AM CDT
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, and HemaCare Corporation, (OTCPK:HEMA), a leading supplier of blood derived cells and components for research and clinical applications, today announced a strategic relationship wherein HemaCare will market BioLife's HypoThermosol® and CryoStor® biopreservation media products and HemaCare's blood derived cells to the research and clinical communities.
HemaCare Reports Improved Six Month and Year End Results
Business Wire - Mon Mar 18, 8:00AM CDT
HemaCare Corporation (HEMA) today reported its financial results for the six months and year ended December 31, 2012. For the six month period, revenue rose by 13% to $9.2 million, while the loss from continuing operations decreased by 83% to $214,000 when compared to the year-earlier period. For the year ended December 31, 2012, revenue rose by 10% to $17.9 million, while the loss from continuing operations decreased by 65% to $758,000 compared to the year-earlier period. Total Company income was $1,163,000 for the year ended December 31, 2012 compared with a total Company loss of $805,000 for the year ended December 31, 2011.
Apheresis Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
M2 - Thu Feb 28, 10:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/ztn2dt/apheresis) has announced the addition of the "Apheresis Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering. Apheresis Equipment Market (Plasmapheresis, Photopheresis, Apheresis in Neurological, Renal, Hematological Diseases, Centrifugation, Membrane Filtration, Apheresis Machines and Disposable Kits) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 This report on the global apheresis equipment market includes the different facets of therapeutic apheresis, donor apheresis, and the apheresis devices market. The report covers the performance of various segments of the apheresis market in terms of revenues generated in such segments. The overall market is classified on the basis of the types of applications of apheresis, different procedural modalities of therapeutic apheresis, various technologies employed, and the types of equipmen
Apheresis Market - Applications, Procedures, Devices & Disposables - Forecasts To 2017
M2 - Wed Jan 16, 9:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/sfgngk/apheresis_market) has announced the addition of the "Apheresis Market - Applications (Plasmapheresis, Plateletpheresis,RBC/Erythrocytapheresis,Leukapheresis,Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices & Disposables - Forecasts To 2017" report to their offering. Apheresis is a process in which blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of separated component. Apheresis involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. Apheresis applications market studied in this report is segmented as plasmapheresis, plateletapheresis, erythrocytapheresis, leukapheresis, and other applications based on the various components collected in apheresis collection
(0)
(0)Hemacare Corp (HEMA) Stock Research Links
Scroll down for more posts ▼